Practical Fragments has
written frequently about hot spots, regions on proteins that are predisposed to
bind ligands such as drugs. Determining whether a protein has a hot spot can help
prioritize a target for screening, and one of the more established computational
approaches to do so is FTMap, which we wrote about most recently just a couple
months ago.
While FTMap can tell you whether
a protein has one or more hot spots, it provides few further details, such as which
regions might prefer a hydrogen bond donor or acceptor. This has now been
addressed in a new J. Chem. Inf. Mod. paper by Sandor Vajda and collaborators
at Boston University, Stony Brook University, and Acpharis. (Diane Joseph-McCarthy
presented some of this work at the CHI DDC conference earlier this month.)
The original version of FTMap started
with a collection of 16 very small molecule probes: these were docked all over
a protein, with hot spots being identified as consensus sites where many probes
bound. To get more information about each hot spot, the researchers have
extended the method – now called E-FTMap – by increasing the number of probes
to 119 covering key functional groups. For example, whereas FTMap included dimethyl
ether as a probe, E-FTMap also includes 2-methoxypropane,
2-methoxy-2-methylpropane, and tetrahydropyran. If all these probes bind with
the oxygen in the same part of the hot spot, this suggests a predilection for a
hydrogen bond acceptor, and also provides information about nearby hydrophobic
contacts.
By using a sufficiently diverse
group of virtual probes, E-FTMap is able to more finely detail hot spots, tallying
the “atomic consensus sites” within them. This is reminiscent of an approach we
wrote about several years ago, though that method used just three different
probes.
To benchmark E-FTMap, the
researchers took 109 fragment-to-lead pairs with published crystallographic
information and assessed whether the program could identify interactions that had
been experimentally observed. The results were encouraging and far superior to
the original version of FTMap. The highest ranked atomic consensus sites
generally overlapped with appropriate atoms in fragments and leads. Interestingly,
the results for fragments were better than those for leads, and the researchers
suggest this is because the fragment “core is responsible for the bulk of the
binding free energy in a ligand and that larger ligands bind by forming additional
interactions at weaker hot spots that surround the fragment binding site.”
Next, E-FTMap was tested against
five proteins for which between 31 and 353 fragment-bound crystal structures
were available. Here too the program was broadly successful, though some fragments
bound regions of the protein that E-FTMap overlooked, particularly in cases
where there were conformational changes. This is not surprising given that the program
assumes the protein remains rigid. (Other computational approaches such as SWISH,
which we wrote about here, are starting to account for protein flexibility.)
E-FTMap looks qualitatively at
specific atomic interactions, and one question I had was how well
the atomic consensus sites matched up with binding affinities of known fragments; perhaps some crystallographically identified fragments bind
so weakly one would not expect to find them computationally, as we discussed here and here. This
hypothesis might be tested by focusing on comparisons with experimentally
characterized fragments with the highest ligand efficiencies.
Also, I was struck by the fact
that the virtual probes in E-FTMap are roughly the size of MiniFrags or
MicroFrags, and I couldn’t help but wonder how well the atomic consensus sites
from the virtual screens would correlate with the binding modes of these tiniest
of fragments.
One nice feature of E-FTMap is that
it can be accessed through a simple web server, so if you’re interested in
these and other questions you can test it for yourself. If you do, please share
your experiences.
No comments:
Post a Comment